Human medicines European public assessment report (EPAR): Kayshild, semaglutide, Date of authorisation: 26/03/2026, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 9 April 2026 - 16:00

Human medicines European public assessment report (EPAR): Kayshild, semaglutide, Date of authorisation: 26/03/2026, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/kayshild

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters